C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2011
10/06/2011	US20110245178 Exendin Fusion Proteins
10/06/2011	US20110245146 Non-Viral Delivery of Compounds to Mitochondria
10/06/2011	US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/06/2011	US20110245093 Functional protein arrays
10/06/2011	US20110244576 Herpes Simplex Virus Complex
10/06/2011	US20110244575 Methods, systems and compositions for increased microorganism tolerance to and production of 3-hydroxypropionic acid (3-hp)
10/06/2011	US20110244574 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/06/2011	US20110244568 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244566 Enhanced efficiency of induced pluripotent stem cell generation
10/06/2011	US20110244563 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators
10/06/2011	US20110244562 Rna interference suppression of neurodegenerative diseases and methods of use thereof
10/06/2011	US20110244561 siRNA-MEDIATED GENE SILENCING
10/06/2011	US20110244552 Methods and compositions for the production of recombinant virus vectors
10/06/2011	US20110244550 Factor ix polypeptide mutant, its uses and a method for its production
10/06/2011	US20110244548 DNA Polymerases Having Improved Labeled Nucleotide Incorporation Properties
10/06/2011	US20110244536 Fermentive production of isobutanol using highly effective ketol-acid reductoisomerase enzymes
10/06/2011	US20110244525 Microorganism expressing xylose isomerase
10/06/2011	US20110244520 Compositions and Methods for Bacterial Production of Chondroitin
10/06/2011	US20110244518 Prokaryotic Expression of Soluble, Active Dkk
10/06/2011	US20110244517 System for antibody expression and assembly
10/06/2011	US20110244515 Method of preparing protein having high content of specific amino acid by co-expression with trna of specific amino acid
10/06/2011	US20110244514 Mammalian Sweet Taste Receptors
10/06/2011	US20110244513 Isolated mammalian membrane protein genes; related reagents
10/06/2011	US20110244496 Hiv reverse transcriptase compositions and methods
10/06/2011	US20110244474 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
10/06/2011	US20110244472 Cancer stem cell immortalization
10/06/2011	US20110244471 Screening method and vector, vector library, and assay kit used therefor
10/06/2011	US20110244469 Method for quantifying initial concentration of nucleic acid from real-time nucleic acid amplification data
10/06/2011	US20110244450 Primate totipotent and pluripotent stem cells produced by somatic cell nuclear transfer
10/06/2011	US20110244446 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244025 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
10/06/2011	US20110244024 Microrna compositions and methods for the treatment of myelogenous leukemia
10/06/2011	US20110243995 Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and Correspondingly Mutated MDM2-Protein Specific Alpha/Beta T-Cell Receptors
10/06/2011	US20110243992 Methods of enhancing the immunogenicity of mycobacteria and compositions for the treatment of cancer, tuberculosis, and fibrosing lung diseases
10/06/2011	US20110243989 Idna vaccines and methods for using the same
10/06/2011	US20110243986 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
10/06/2011	US20110243978 Enterococcus antigens
10/06/2011	US20110243976 Compositions comprising pneumococcal antigens
10/06/2011	US20110243975 Transformed soybean plant which accumulates vaccine, and use thereof
10/06/2011	US20110243974 Novel tumor antigen protein sart-3 and tumor antigen peptides thereof
10/06/2011	US20110243973 Hig2 and urlc10 epitope peptide and vaccines containing the same
10/06/2011	US20110243968 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
10/06/2011	US20110243966 SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO
10/06/2011	US20110243964 Treatment of orthopedic conditions
10/06/2011	US20110243963 Antibodies to lrp6
10/06/2011	US20110243962 Therapeutic use of specific ligand in msrv associated diseases
10/06/2011	US20110243960 Methods and compositions for treating p. acnes
10/06/2011	US20110243953 Neutralizing antibodies against gdf-8 and uses therefor
10/06/2011	US20110243950 Msp2 antigenic peptides and their use
10/06/2011	US20110243942 Relaxin-fusion proteins with extended in vivo half-lives
10/06/2011	US20110243939 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243929 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/06/2011	US20110243916 Modified endolysin ply511
10/06/2011	US20110243915 Antimicrobial agents
10/06/2011	US20110243912 Growth Factor Binding Constructs Materials and Methods
10/06/2011	US20110243904 Rna interference target for treating aids
10/06/2011	US20110243899 Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein
10/06/2011	US20110243897 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
10/06/2011	US20110243888 Il-29 mutants and uses thereof
10/06/2011	US20110243887 Il-7 fusion proteins
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	DE102010013887A1 Fusionsprotein und dessen Verwendungen Fusion protein and uses thereof
10/06/2011	CA2795400A1 Prevention and treatment of cast nephropathy
10/06/2011	CA2795318A1 Ect2 peptides and vaccines including the same
10/06/2011	CA2795145A1 Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3
10/06/2011	CA2795084A1 Polyamine-containing polymers and methods of synthesis and use
10/06/2011	CA2795043A1 Humanized il-25 antibodies
10/06/2011	CA2794930A1 Method for inhibiting hiv replication in mammal and human cells
10/06/2011	CA2794882A1 Method for producing zeaxanthin by fermentation
10/06/2011	CA2794800A1 Method for improving detection of b cell immunoglobulin gene recombination
10/06/2011	CA2794740A1 Methods for g-csf production in a pseudomonas host cell
10/06/2011	CA2794471A1 Novel cellulase gene
10/06/2011	CA2794392A1 Transcription factor decoys
10/06/2011	CA2794332A1 Anti-cd40 antibodies
10/06/2011	CA2794318A1 Method of enhancing the seed yield and promoting the growth of plants
10/06/2011	CA2794311A1 Macrocyclic lactone resistance marker for dirofilaria immitis
10/06/2011	CA2793794A1 Tools for the identification of lingo-1, lingo-2, lingo-3 and lingo-4, ligands, and uses thereof
10/06/2011	CA2793692A1 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain
10/06/2011	CA2787498A1 Genetic engineering of non-human animals for the production of chimeric antibodies
10/06/2011	CA2775971A1 Metabolic evolution of escherichia coli strains that produce organic acids
10/05/2011	EP2371970A2 Methods for purifying and detecting double stranded DNA target sequences by triple helix interection
10/05/2011	EP2371967A1 Production of carotenoids in oleaginous yeast and fungi
10/05/2011	EP2371966A1 Recombinant lentiviral vector for expression of a Flaviviridae protein and applications thereof as a vaccine
10/05/2011	EP2371964A1 Use of non-agrobacterium bacterial species for plant transformation
10/05/2011	EP2371963A1 Protein production in filamentous fungi
10/05/2011	EP2371962A2 Receptor activator of NF-KAPPA B, receptor is member of TNF receptor superfamily
10/05/2011	EP2371961A1 Method for isolation of soluble polypeptides
10/05/2011	EP2371960A2 Method for isolation of soluble polypeptides
10/05/2011	EP2371959A2 Treatment of neurodegenerative disease through intracranial delivery of siRNA
10/05/2011	EP2371958A1 Novel siRNAs and methods of use thereof
10/05/2011	EP2371957A1 Compositions and their uses directed to hepcidin
10/05/2011	EP2371956A2 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
10/05/2011	EP2371955A1 Integrase cofactor
10/05/2011	EP2371954A1 Compositions and methods for short interfering nucleic acid inhibition of NAv1.8
10/05/2011	EP2371953A1 Fluorescent protein
10/05/2011	EP2371952A1 Bacterium capable of producing 2-deoxy-scyllo-inosose (doi), and process for producing 2-deoxy-scyllo-inosose (doi) by using same
10/05/2011	EP2371951A1 NOVEL MutS PROTEIN AND METHOD OF USING SAME TO DETERMINE MUTATIONS
10/05/2011	EP2371947A1 Enhanced promoter and method for producing L-lysine usinge the same
10/05/2011	EP2371945A1 IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN

1 ... 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 ... 4023